Skip to content

Vision Baby : The Measurement of Vital Signs in Neonates by Lifelight® Software in Comparison to the Standard of Care

The Measurement of Vital Signs in Neonates by Lifelight® Software in Comparison to the Standard of Care

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07799870
Acronym
Vision Baby
Enrollment
256
Registered
2026-09-02
Start date
2025-03-01
Completion date
2027-07-01
Last updated
2026-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Diseases and Abnormalities, Vital Sign Monitoring

Brief summary

This is a non-invasive basic science study that will meet the study objectives by recruiting 256 participants in the NICU. The study will also include sub-protocols for parents/carers/guardians of eligible participants to complete post measurement questionnaires. Each participant will have their HR, RR, SpO2, BP, ECG and temperature measured continuously using standard of-care equipment and methods. At the same time, video of the participant's face and parts of the torso with exposed skin will be captured 4 times every hour (every 15 minutes) using the Data Collect app running on a tablet positioned above the neonate's cot. The video recorded using the app will be uploaded to the cloud for subsequent analysis and processing aligned to the study's primary and secondary objectives only. The app will not return any measurements to the user or participant. The video may be recorded for up to 120 seconds each time. There will be a maximum of three attempts at recording measurements. Most of the data collected will be used to "train" the existing Lifelight algorithms to measure VS in neonates and infants. The remaining data will be kept separate and used to assess the accuracy of the algorithms at regular intervals during the dataset collection period. The study delivery process will be responsive to this learning curve to increase the likelihood that predetermined accuracies for each VS estimation algorithm are achieved by study end.

Interventions

None listed

Sponsors

Xim Limited
Lead SponsorINDUSTRY
Barts & The London NHS Trust
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
0 Months to 12 Months
Healthy volunteers
No

Inclusion criteria

* Infants admitted to the NICU (who may subsequently be moved onto a different inpatient ward)

Exclusion criteria

* Infants who are on a palliative care pathway

Design outcomes

Primary

MeasureTime frameDescription
Data Collection2 yearsCollected the data needed to develop Lifelight Baby so that it can measure pulse rate and respiratory rate, and estimate oxygen saturation and blood pressure.

Countries

United Kingdom

Contacts

CONTACTLaurence Pearce, MBA
laurence@xim.ai+447803950356
PRINCIPAL_INVESTIGATORBurak Salgin, BA MD BChir PhD

Barts & The London NHS Trust

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 3, 2026